<!doctype html>
<html>
<head>
<meta charset="utf-8">
<meta name="viewport" content="width=device-width">
<title></title>
<link rel="stylesheet" href="css/style.css">
</head>

<body>

<header>
  <div class="l"><a href="javascript:history.back();"><span>left</span></a></div>
  <p class="title"><a href="index.html">社外秘 研修資料</a></p>
  <div class="r"><a href="121_024.html"><span>right</span></a></div>
</header>

<div class="wrap">
  <div class="clearfix">
<img src="img04/ver4.png" alt="ver4" width="50" height="20" style="float: right;">
</div>

  <section>
    <h1 class="tit">エンブレルMonoはMTXと有意差がない</h1>
    <p class="txt big">TCZとETN単独療法のMTXへの優越性の検討</p>
    <h2 class="tit"><u>MTX naïve RA患者に対するMTXと生物学的製剤単独療法の有効性比較</u></h2>
  </section>

  <section>


     <div class="img"><img src="img_etn-bs/23_1.png"></div>

   <p class="txt"><a href="http://maps.ty.chugai-pharm.co.jp/Search/Detail.aspx?id=D37561&skey=2b7aaa79-b1e1-4b0e-a2ca-cee55438ae7c">Jones G, et al. Ann Rheum Dis 2010;69:88–96.</a></p>


      <div class="img"><img src="img_etn-bs/23_2.png"></div>
      <p class="txt"><a href="http://maps.ty.chugai-pharm.co.jp/Search/Detail.aspx?id=D15830&skey=f86f1738-f6f3-452a-a3b9-d69f2a19a73d">Bathon JM, et al. NEJM. 2000 Nov 30;343(22):1586.</a></p>

<p><font color="red">注：JAK阻害薬のトファチニブ、バリシチニブは単剤でMTXより優れるデータあり</font></p>
</section>
</div>

<footer>
  <div class="l"><a href="javascript:history.back();"><span>left</span></a></div>
  <div class="home"><a href="index.html"><span>HOME</span></a></div>
  <div class="r"><a href="121_024.html"><span>right</span></a></div>
  <div class="pagetop"><a href="javascript:scroll(0,0);">pagetop</a></div>
</footer>

<script src="https://ajax.googleapis.com/ajax/libs/jquery/1.8.2/jquery.min.js"></script>
<script src="js/common.js"></script>
</body>
</html>
